FOLFOX induced PD-L1 tumor cell expression and stimulated CD8+ T cell infiltration in CRC patients indicating anti-PD1 therapy may be used effectively in combination with FOLFOX for CRC treatment [141]. The gene discussed is CD274; the disease is neoplasm.